Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis
Michael David, Martina Del Giovane, Kathy Liu, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 93, Iss. 10, pp. 1080-1090
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers
Dongmin Bang, Sangsoo Lim, Sangseon Lee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 53
Noradrenergic and cholinergic systems take centre stage in neuropsychiatric diseases of ageing
Isabella F. Orlando, James M. Shine, Trevor W. Robbins, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105167-105167
Open Access | Times Cited: 33
The integrity of dopaminergic and noradrenergic brain regions is associated with different aspects of late-life memory performance
Martin J. Dahl, Shelby L. Bachman, Shubir Dutt, et al.
Nature Aging (2023) Vol. 3, Iss. 9, pp. 1128-1143
Open Access | Times Cited: 31
Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's disease
Michael A. Kelberman, Jacki M. Rorabaugh, Claire R. Anderson, et al.
Neurobiology of Aging (2023) Vol. 125, pp. 98-108
Open Access | Times Cited: 27
Declining locus coeruleus–dopaminergic and noradrenergic modulation of long-term memory in aging and Alzheimer’s disease
Martin J. Dahl, Agnieszka Kulesza, Markus Werkle‐Bergner, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 153, pp. 105358-105358
Open Access | Times Cited: 21
Digging into the intrinsic capacity concept: Can it be applied to Alzheimer’s disease?
Susana López‐Ortiz, Giuseppe Caruso, Enzo Emanuele, et al.
Progress in Neurobiology (2024) Vol. 234, pp. 102574-102574
Closed Access | Times Cited: 6
Noradrenergic neuromodulation in ageing and disease
Friedrich Krohn, Elisa Lancini, Mareike Ludwig, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105311-105311
Open Access | Times Cited: 12
Apathy and Motivation: Biological Basis and Drug Treatment
Harry Costello, Masud Husain, Jonathan P. Roiser
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 313-338
Open Access | Times Cited: 12
State‐of‐the‐art therapy for Down syndrome
Nicola Lorenzón, Juanluis Musoles‐Lleó, Federica Turrisi, et al.
Developmental Medicine & Child Neurology (2023) Vol. 65, Iss. 7, pp. 870-884
Closed Access | Times Cited: 11
Non-coding RNAs involved in the molecular pathology of Alzheimer’s disease: a systematic review
Reynand Jay Canoy, J Sy, Christian Deo T. Deguit, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Light‐exercise‐induced dopaminergic and noradrenergic stimulation in the dorsal hippocampus: Using a rat physiological exercise model
Taichi Hiraga, Toshiaki Hata, Shingo Soya, et al.
The FASEB Journal (2024) Vol. 38, Iss. 24
Open Access | Times Cited: 4
The Contribution of the Locus Coeruleus–Noradrenaline System Degeneration during the Progression of Alzheimer’s Disease
Dilek Mercan, Michael T. Heneka
Biology (2022) Vol. 11, Iss. 12, pp. 1822-1822
Open Access | Times Cited: 18
Apathy in Alzheimer’s disease: A neurocircuitry based perspective
Sonam Fathima Mehak, Apoorva Bettagere Shivakumar, Vikyath Saraf, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101891-101891
Closed Access | Times Cited: 10
Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better?
Ece Bayram, Lucia Batzu, Bension S. Tilley, et al.
Parkinsonism & Related Disorders (2023) Vol. 112, pp. 105385-105385
Open Access | Times Cited: 9
Locus Coeruleus Dysfunction and Trigeminal Mesencephalic Nucleus Degeneration: A Cue for Periodontal Infection Mediated Damage in Alzheimer’s Disease?
Flavio Pisani, Valerio Pisani, Francesca Arcangeli, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 2, pp. 1007-1007
Open Access | Times Cited: 8
Amphetamines Improve the Motivation to Invest Effort in Attention-Deficit/Hyperactivity Disorder
Trevor T.‐J. Chong, Erika Fortunato, Mark A. Bellgrove
Journal of Neuroscience (2023) Vol. 43, Iss. 41, pp. 6898-6908
Open Access | Times Cited: 7
Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology
Efthalia Angelopoulou, Anastasia Bougea, Alexandros Hatzimanolis, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1164-1164
Open Access | Times Cited: 2
Noradrenergic modulation of saccades in Parkinson’s disease
Isabella F. Orlando, Frank H. Hezemans, Rong Ye, et al.
Brain Communications (2024) Vol. 6, Iss. 5
Open Access | Times Cited: 2
Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in the Alzheimer's disease continuum
Caterina Motta, Martina Assogna, Chiara Giuseppina Bonomi, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 4, pp. 839-848
Open Access | Times Cited: 6
Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease
Rachel A. Matt, Renée S. Martin, Andrew K. Evans, et al.
Handbook of experimental pharmacology (2023)
Closed Access | Times Cited: 6
Sleep spindle architecture associated with distinct clinical phenotypes in older adults at risk for dementia
Isabella F. Orlando, Claire O’Callaghan, Aaron Lam, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 2, pp. 402-411
Open Access | Times Cited: 6
Connecting the Emotional-Cognitive Puzzle: The Role of Tyrosine Kinase (TrkB) Receptor Isoform Imbalance in Age-Related Emotional and Cognitive impairments
Noa Bregman-Yemini, Keren Nitzan, Motty Franko, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102349-102349
Closed Access | Times Cited: 1
Amphetamine and methylphenidate potential on the recovery from stroke and traumatic brain injury: a review
Mariana Ferreira, Patrı́cia Carneiro, Vera Marisa Costa, et al.
Reviews in the Neurosciences (2024) Vol. 35, Iss. 7, pp. 709-746
Closed Access | Times Cited: 1
Alzheimer’s Disease-Related Phospho-Tau181 Signals Are Localized to Demyelinated Axons of Parvalbumin-Positive GABAergic Interneurons in an App Knock-In Mouse Model of Amyloid-β Pathology
Yu Hirota, Yasufumi Sakakibara, Kimi Takei, et al.
Journal of Alzheimer s Disease (2023) Vol. 93, Iss. 3, pp. 1065-1081
Open Access | Times Cited: 3
Locus coeruleus ablation in mice: protocol optimization, stereology and behavioral impact
Nanna Bertin Markussen, Rasmus West Knopper, Stine Hasselholt, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top